[2] et alMolecular docking and dynamics studies of curcumin with COVID-19 proteins[J]. Network Modeling and Analysis in Health Informatics and Bioinformatics, 10, 44-54(2021).

[3] et alAntiviral and immunomodulatory activity of curcumin: A case for prophylactic therapy for COVID-19[J]. Heliyon, 7, e06350(2021).

[4] Curcumin (a constituent of turmeric): New treatment option against COVID-19[J]. Food Science & Nutrition, 8, 5215-5227(2020).

[6] et alRuthenium(Ⅱ)-curcumin liposome nanoparticles: Synthesis, characterization, and effects against cervical cancer[J]. Colloids and Surfaces B: Biointerfaces, 111773(2021).

[10] et alCurcumin-loaded liposomes with the hepatic and lysosomal dualtargeted effects for therapy of hepatocellular carcinoma[J]. International Journal of Pharmaceutics, 602, 120628(2021).

[12] et alProduction of polyhydroxyalkanoates (PHA) by a thermophilic strain of schlegelella thermodepolymerans from xylose rich substrates[J]. Bioresource Technology, 315, 123885(2020).

[13] et alAdvances in polyhydroxyalkanoate nanocarriers for effective drug delivery: An overview and challenges[J]. Nanomaterials (Basel), 12, 175-179(2022).

[14] et alA novel long-acting azathioprine polyhydroxyalkanoate nanoparticle enhances treatment efficacy for systemic lupus erythematosus with reduced side effects[J]. Nanoscale, 12, 10799-10808(2022).

[15] et alPolyester nanomedicines targeting inflammatory signaling pathways for cancer therapy[J]. Biomed Pharmacother, 154, 113654(2022).